Responses
Immunotherapy biomarkers
Original research
Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.